Role of Matrix Metalloproteinases in Angiogenesis and Cancer.

MMP MT-MMP angiogenesis and cancer immune system metalloproteinases

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2019
Historique:
received: 24 06 2019
accepted: 20 11 2019
entrez: 11 1 2020
pubmed: 11 1 2020
medline: 11 1 2020
Statut: epublish

Résumé

During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metalloproteinases (MMPs) participate in the disruption, tumor neovascularization, and subsequent metastasis while tissue inhibitors of metalloproteinases (TIMPs) downregulate the activity of these MMPs. Then, the angiogenic response can be directly or indirectly mediated by MMPs through the modulation of the balance between pro- and anti-angiogenic factors. This review analyzes recent knowledge on MMPs and their participation in angiogenesis.

Identifiants

pubmed: 31921634
doi: 10.3389/fonc.2019.01370
pmc: PMC6915110
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1370

Informations de copyright

Copyright © 2019 Quintero-Fabián, Arreola, Becerril-Villanueva, Torres-Romero, Arana-Argáez, Lara-Riegos, Ramírez-Camacho and Alvarez-Sánchez.

Références

Br J Cancer. 2014 Jan 21;110(2):441-9
pubmed: 24292449
Nat Rev Cancer. 2003 Oct;3(10):721-32
pubmed: 13130303
Nat Cell Biol. 2008 Dec;10(12):1470-6
pubmed: 19011622
Med Sci Monit. 2012 Apr;18(4):BR130-4
pubmed: 22460086
Dev Cell. 2010 Jun 15;18(6):884-901
pubmed: 20627072
Int J Cancer. 2012 Oct 1;131(7):1537-48
pubmed: 22262494
Int J Mol Med. 2015 Jun;35(6):1729-33
pubmed: 25846944
Proc Natl Acad Sci U S A. 2015 May 12;112(19):E2487-96
pubmed: 25918379
Cancer Res. 2006 Mar 1;66(5):2650-7
pubmed: 16510584
Circ Res. 2007 Mar 30;100(6):904-13
pubmed: 17322177
Tumour Biol. 2016 Mar;37(3):3505-14
pubmed: 26453114
Oncotarget. 2016 Sep 20;7(38):62425-62438
pubmed: 27613828
Bioengineering (Basel). 2018 Sep 20;5(4):null
pubmed: 30241287
J Cell Biol. 1988 May;106(5):1659-65
pubmed: 2967299
Phytomedicine. 2018 Nov 15;50:35-42
pubmed: 30466990
Breast Cancer Res. 2008;10(6):R95
pubmed: 19014637
Oncotarget. 2016 Jul 26;7(30):48193-48205
pubmed: 27374080
Oncogene. 2015 Feb 12;34(7):890-901
pubmed: 24561529
Cancer Med. 2018 Oct;7(10):5118-5129
pubmed: 30256540
Cancer Cell Int. 2019 Apr 30;19:116
pubmed: 31068761
Front Immunol. 2018 Mar 06;9:334
pubmed: 29559970
Biomedicines. 2017 Jun 21;5(2):
pubmed: 28635679
Front Immunol. 2014 Apr 02;5:144
pubmed: 24765093
J Cell Biochem. 2017 Apr;118(4):851-859
pubmed: 27735991
Nat Cell Biol. 2000 Oct;2(10):737-44
pubmed: 11025665
Cell Signal. 2013 Sep;25(9):1780-91
pubmed: 23714383
Crit Rev Oncog. 2013;18(1-2):43-73
pubmed: 23237552
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5113-5121
pubmed: 31298364
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Cell Res. 1998 Sep;8(3):171-7
pubmed: 9791730
Cytokine. 2016 Oct;86:64-72
pubmed: 27468958
Nat Rev Cancer. 2003 Jun;3(6):411-21
pubmed: 12778131
Front Pharmacol. 2019 May 03;10:462
pubmed: 31130862
Semin Reprod Endocrinol. 1997;15(3):221-7
pubmed: 9383830
Mol Carcinog. 2015 Dec;54(12):1686-99
pubmed: 25358651
Oncol Rep. 2017 Mar;37(3):1779-1785
pubmed: 28184939
Cancer Cell. 2004 Dec;6(6):553-63
pubmed: 15607960
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Cardiovasc Res. 2006 Feb 15;69(3):562-73
pubmed: 16405877
Nat Rev Cancer. 2017 Aug;17(8):457-474
pubmed: 28706266
Int J Mol Sci. 2018 Dec 04;19(12):null
pubmed: 30518157
Neoplasia. 2016 Jul;18(7):447-56
pubmed: 27435927
Clin Cancer Res. 2009 Jun 1;15(11):3648-53
pubmed: 19470735
Cardiovasc Res. 2013 Jul 1;99(1):146-55
pubmed: 23512982
Glia. 2008 Nov 15;56(15):1679-90
pubmed: 18563800
Biochim Biophys Acta. 2004 Dec 17;1705(2):69-89
pubmed: 15588763
Oncogene. 2017 Feb 2;36(5):687-699
pubmed: 27375020
Genome Biol. 2015 May 30;16:113
pubmed: 26025392
J Biol Chem. 1997 Nov 14;272(46):28823-5
pubmed: 9360944
J Biol Chem. 2009 Jun 5;284(23):15353-7
pubmed: 19201757
Int J Med Sci. 2013;10(3):276-85
pubmed: 23372434
J Cancer. 2017 Feb 25;8(5):761-773
pubmed: 28382138
PLoS One. 2017 Jun 28;12(6):e0180097
pubmed: 28658303
J Biol Chem. 2001 Jun 8;276(23):20572-8
pubmed: 11279151
Mol Cell Proteomics. 2010 Jun;9(6):1085-99
pubmed: 20124223
Histol Histopathol. 2016 Apr;31(4):379-91
pubmed: 26662176
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20318-23
pubmed: 19915148
Ther Adv Med Oncol. 2019 Jul 16;11:1758835919864247
pubmed: 31360238
Nat Rev Cancer. 2010 Jul;10(7):505-14
pubmed: 20574450
J Immunol. 2003 Mar 15;170(6):3369-76
pubmed: 12626597
Cell Signal. 2013 Oct;25(10):2025-38
pubmed: 23770289
Neuroscience. 2010 Jun 30;168(2):514-22
pubmed: 20382206
Genes Environ. 2019 Jul 22;41:16
pubmed: 31367263
Cancer Biomark. 2018 Feb 14;21(3):661-673
pubmed: 29278881
Cancer Cell. 2003 Jun;3(6):589-601
pubmed: 12842087
Exp Cell Res. 2013 May 15;319(9):1281-8
pubmed: 23328307
Rom J Morphol Embryol. 2010;51(2):215-28
pubmed: 20495735
Eur J Cell Biol. 2016 Nov;95(11):427-440
pubmed: 27397693
Cell. 2011 Oct 14;147(2):275-92
pubmed: 22000009
J Cell Physiol. 2017 Dec;232(12):3468-3480
pubmed: 28098359
FASEB J. 2002 Apr;16(6):555-64
pubmed: 11919158
Am J Surg. 2017 Nov;214(5):938-944
pubmed: 28830617
Oncotarget. 2018 Aug 24;9(66):32556-32569
pubmed: 30220965
Cancers (Basel). 2014 Feb 10;6(1):366-75
pubmed: 24518611
Nature. 2011 May 19;473(7347):298-307
pubmed: 21593862
Sci Rep. 2017 Aug 17;7(1):8526
pubmed: 28819304
Int J Cancer. 2009 Dec 15;125(12):2747-56
pubmed: 19569051
Cell Oncol (Dordr). 2016 Oct;39(5):397-410
pubmed: 27126599
J Biol Chem. 1997 Dec 12;272(50):31504-9
pubmed: 9395486
Cytokine Growth Factor Rev. 2005 Apr;16(2):159-78
pubmed: 15863032
Oncol Lett. 2016 Feb;11(2):1043-1050
pubmed: 26893688
J Cancer Res Clin Oncol. 2013 Apr;139(4):533-42
pubmed: 23207790
J Clin Med. 2017 Jan 06;6(1):
pubmed: 28067804
J Exp Clin Cancer Res. 2016 Feb 04;35:27
pubmed: 26847351
Biochem Biophys Res Commun. 2013 Jul 26;437(2):232-8
pubmed: 23796708
Asian Pac J Cancer Prev. 2012;13(7):3259-64
pubmed: 22994744
Genes Dev. 2000 Jan 15;14(2):163-76
pubmed: 10652271
J Clin Invest. 1999 May;103(9):1237-41
pubmed: 10225966
Trends Cell Biol. 2003 Jul;13(7):366-75
pubmed: 12837607
Pharmacol Ther. 2016 Dec;168:98-112
pubmed: 27613100
BMC Cancer. 2015 Jun 05;15:456
pubmed: 26043921
Front Pharmacol. 2011 May 13;2:111
pubmed: 21687519
Oncoimmunology. 2013 May 1;2(5):e24010
pubmed: 23762791
J Clin Invest. 2008 May;118(5):1727-38
pubmed: 18431520
J Biol Chem. 2016 Dec 30;291(53):27265-27278
pubmed: 27852824
Int J Cancer. 2011 Oct 15;129(8):1826-37
pubmed: 21165953
Biomed Pharmacother. 2018 Jul;103:262-271
pubmed: 29656182
Curr Opin Cell Biol. 2004 Oct;16(5):558-64
pubmed: 15363807
Cancer Res. 2010 May 15;70(10):4141-50
pubmed: 20424116
Biochim Biophys Acta. 2010 Jan;1803(1):20-8
pubmed: 19374923
Br J Cancer. 2010 Feb 2;102(3):530-40
pubmed: 20087345
Mol Cancer. 2014 Jan 31;13:18
pubmed: 24479681
Oncotarget. 2017 Mar 28;8(13):20741-20750
pubmed: 28186964
Thorax. 2017 Dec;72(12):1140-1143
pubmed: 28202627
J Cell Sci. 2010 Dec 1;123(Pt 23):4182-93
pubmed: 21062896
Cancer Res. 2013 Jul 15;73(14):4196-211
pubmed: 23687338
Br J Cancer. 2000 Dec;83(11):1538-43
pubmed: 11076665
Nat Rev Cancer. 2002 Jun;2(6):442-54
pubmed: 12189386
Sci Rep. 2018 May 8;8(1):7199
pubmed: 29740050
J Cell Biochem. 2015 Dec;116(12):2766-77
pubmed: 25959126
J Biol Chem. 2007 Jul 27;282(30):21998-2010
pubmed: 17513868
Cancer Res. 2017 Dec 1;77(23):6480-6488
pubmed: 29162616
J Biol Chem. 2004 Mar 5;279(10):8592-601
pubmed: 14681236
Circ Res. 2003 May 2;92(8):827-39
pubmed: 12730128
Proc Natl Acad Sci U S A. 1962 Jun 15;48:1014-22
pubmed: 13902219
J Enzyme Inhib Med Chem. 2016;31(sup1):177-183
pubmed: 27028474
J Biol Chem. 2007 Mar 2;282(9):6899-905
pubmed: 17204469
Oncotarget. 2017 May 16;8(20):33501-33514
pubmed: 28432279
J Hematol Oncol. 2017 Feb 1;10(1):36
pubmed: 28143526
Biochim Biophys Acta. 2015 Dec;1852(12):2593-602
pubmed: 26343184
J Natl Cancer Inst. 1968 Dec;41(6):1329-41
pubmed: 5750121
Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16314-16319
pubmed: 31363054
Oncol Rep. 2008 Apr;19(4):1007-13
pubmed: 18357389
Exp Biol Med (Maywood). 2017 Mar;242(6):573-583
pubmed: 28058861
Front Immunol. 2017 Mar 08;8:205
pubmed: 28337194
J Pathol. 2017 Apr;241(5):638-648
pubmed: 28026024
Dermatology. 2019;235(3):225-233
pubmed: 30928981
Blood. 2000 Oct 15;96(8):2673-81
pubmed: 11023497
Gastroenterology. 2018 Feb;154(3):675-688
pubmed: 28989066
Am J Pathol. 2011 Sep;179(3):1455-70
pubmed: 21741942
J Biol Chem. 2013 Jan 4;288(1):598-607
pubmed: 23155052
Blood. 2009 Mar 5;113(10):2363-9
pubmed: 18974372
PLoS One. 2015 Mar 16;10(3):e0116006
pubmed: 25774665
Oncol Rep. 2017 Mar;37(3):1907-1913
pubmed: 28112361
Korean J Physiol Pharmacol. 2014 Oct;18(5):391-6
pubmed: 25352758
Cells. 2018 Jul 28;7(8):null
pubmed: 30060564
J Biol Chem. 2002 Jun 14;277(24):21352-60
pubmed: 11929865
Mol Immunol. 2017 Oct;90:126-135
pubmed: 28715683
BMC Cancer. 2016 Aug 22;16:665
pubmed: 27549240
J Transl Med. 2011 Dec 16;9:216
pubmed: 22176642
Cancers (Basel). 2013 May 27;5(2):617-38
pubmed: 24216994
Cancer J. 2015 Jul-Aug;21(4):267-73
pubmed: 26222078
Gut. 2012 Nov;61(11):1560-7
pubmed: 22213796
Mol Cancer. 2019 Mar 30;18(1):57
pubmed: 30925935
Cancer Res. 1999 Aug 15;59(16):4111-8
pubmed: 10463616
Cancers (Basel). 2014 Feb 13;6(1):396-415
pubmed: 24531055
J Cell Sci. 2010 Dec 15;123(Pt 24):4195-200
pubmed: 21123617
J Clin Exp Dent. 2016 Apr 01;8(2):e130-5
pubmed: 27034751
J Cell Mol Med. 2009 Sep;13(9B):4002-13
pubmed: 19426156
PLoS One. 2015 Sep 17;10(9):e0137923
pubmed: 26378920
ScientificWorldJournal. 2014 Jan 21;2014:521754
pubmed: 24578639
Oncotarget. 2017 Nov 20;8(62):106071-106088
pubmed: 29285315
Oncogene. 2012 Oct 18;31(42):4499-508
pubmed: 22179834
Am J Pathol. 1997 Oct;151(4):1105-13
pubmed: 9327744
Nat Rev Cancer. 2002 Aug;2(8):563-72
pubmed: 12154349
Onco Targets Ther. 2018 Feb 16;11:843-849
pubmed: 29497316
Onco Targets Ther. 2017 Sep 25;10:4719-4729
pubmed: 29026320
Oral Dis. 2017 Mar;23(2):199-209
pubmed: 27868311
Oncotarget. 2015 Sep 22;6(28):26065-78
pubmed: 26305549
Oncotarget. 2017 Jul 18;8(29):47518-47532
pubmed: 28537901
FASEB J. 2005 Feb;19(2):234-6
pubmed: 15550552
Gene. 2018 Nov 15;676:101-109
pubmed: 30010038
Adv Pharmacol. 2018;81:241-330
pubmed: 29310800
Biochim Biophys Acta. 2010 Jan;1803(1):55-71
pubmed: 20080133
J Cancer. 2018 Sep 7;9(18):3326-3333
pubmed: 30271493
Oncol Rep. 2012 Sep;28(3):1084-90
pubmed: 22710862
Cancer Res. 2008 Oct 1;68(19):7828-37
pubmed: 18829538
Mol Aspects Med. 2008 Oct;29(5):290-308
pubmed: 18619669
Endocrinology. 2011 Sep;152(9):3332-42
pubmed: 21750048
Cancer Res. 2002 Jan 15;62(2):580-8
pubmed: 11809713
Oncotarget. 2016 Jul 19;7(29):45678-45686
pubmed: 27329841
FASEB J. 2018 Oct;32(10):5365-5377
pubmed: 29763380
Matrix Biol. 2016 Jan;49:37-60
pubmed: 26407638
Am J Pathol. 2002 Feb;160(2):673-80
pubmed: 11839588
BMC Cancer. 2017 Jun 20;17(1):434
pubmed: 28633655
Transl Cancer Res. 2018 Jun;7(3):533-542
pubmed: 30221145
J Biol Chem. 2012 Nov 9;287(46):38716-28
pubmed: 22992737
Nat Rev Cancer. 2008 Aug;8(8):618-31
pubmed: 18633355
J Surg Res. 2009 May 15;153(2):274-81
pubmed: 18952231
Pathol Int. 2010 Apr;60(4):278-83
pubmed: 20403029
J Cell Mol Med. 2019 Jul;23(7):4523-4533
pubmed: 31044528
Clin Cancer Res. 2005 Apr 1;11(7):2492-501
pubmed: 15814625
Int J Cancer. 2019 Aug 5;:null
pubmed: 31381135
Oncogene. 2007 Sep 27;26(44):6361-71
pubmed: 17452979
Int J Oncol. 2016 Oct;49(4):1377-84
pubmed: 27511626
Cancer Res. 2014 Dec 1;74(23):6758-70
pubmed: 25320013
Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):101-17
pubmed: 15000152
Nat Rev Mol Cell Biol. 2007 Jun;8(6):464-78
pubmed: 17522591
J Clin Invest. 2008 Oct;118(10):3367-77
pubmed: 18776941
PLoS One. 2010 Dec 08;5(12):e14250
pubmed: 21170377
Oncol Lett. 2018 Oct;16(4):4953-4960
pubmed: 30214613
Mediators Inflamm. 2013;2013:928315
pubmed: 23840100
J Biol Chem. 2001 Jul 27;276(30):28261-7
pubmed: 11375993
Br J Cancer. 2014 Aug 12;111(4):763-71
pubmed: 24937671
Int J Cancer. 2009 Oct 1;125(7):1595-603
pubmed: 19462451
BMC Immunol. 2018 Jan 24;19(1):3
pubmed: 29361917
Cancer Sci. 2006 Dec;97(12):1327-34
pubmed: 16999819
Int J Clin Exp Pathol. 2014 Jun 15;7(7):3694-703
pubmed: 25120745
Circ Res. 2012 Jun 8;110(12):e92-e101
pubmed: 22550139
Exp Cell Res. 2006 Mar 10;312(5):549-60
pubmed: 16336962
J Cell Mol Med. 2005 Apr-Jun;9(2):267-85
pubmed: 15963249

Auteurs

Saray Quintero-Fabián (S)

Multidisciplinary Research Laboratory, Military School of Graduate of Health, Mexico City, Mexico.

Rodrigo Arreola (R)

Psychiatric Genetics Department, National Institute of Psychiatry "Ramón de la Fuente", Clinical Research Branch, Mexico City, Mexico.

Enrique Becerril-Villanueva (E)

Psychoimmunology Laboratory, National Institute of Psychiatry "Ramón de la Fuente", Mexico City, Mexico.

Julio César Torres-Romero (JC)

Biochemistry and Molecular Genetics Laboratory, Facultad de Química de la Universidad Autónoma de Yucatán, Merida, Mexico.

Victor Arana-Argáez (V)

Pharmacology Laboratory, Facultad de Química de la Universidad Autónoma de Yucatán, Mérida, Mexico.

Julio Lara-Riegos (J)

Biochemistry and Molecular Genetics Laboratory, Facultad de Química de la Universidad Autónoma de Yucatán, Merida, Mexico.

Mario Alberto Ramírez-Camacho (MA)

Centro de Información de Medicamentos, Facultad de Química de la Universidad Autónoma de Yucatán, Mérida, Mexico.

María Elizbeth Alvarez-Sánchez (ME)

Genomic Sciences Graduate Program, Universidad Autónoma de la Ciudad de Mexico, Mexico City, Mexico.

Classifications MeSH